首页 > 最新文献
paperpass

Journal of Infectious Disease Pharmacotherapy最新文献

英文 中文
West Nile Virus:: Here to Stay 西尼罗河病毒:留在这里
Pub Date : 2004-09-20 DOI: 10.1300/J100V06N04_02
Deb Schering
{"title":"West Nile Virus:: Here to Stay","authors":"Deb Schering","doi":"10.1300/J100V06N04_02","DOIUrl":"https://doi.org/10.1300/J100V06N04_02","url":null,"abstract":"","PeriodicalId":190875,"journal":{"name":"Journal of Infectious Disease Pharmacotherapy","volume":"41 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2004-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134228155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmacokinetic Profiles of Intravenous Ciprofloxacin 600 Milligram 静脉注射环丙沙星600毫克的药动学特征
Pub Date : 2004-09-20 DOI: 10.1300/J100V06N04_03
H. Mikamo
{"title":"Pharmacokinetic Profiles of Intravenous Ciprofloxacin 600 Milligram","authors":"H. Mikamo","doi":"10.1300/J100V06N04_03","DOIUrl":"https://doi.org/10.1300/J100V06N04_03","url":null,"abstract":"","PeriodicalId":190875,"journal":{"name":"Journal of Infectious Disease Pharmacotherapy","volume":"94 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2004-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131568897","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Community-acquired pneumonia: Objective criteria to predict severe disease 社区获得性肺炎:预测重症的客观标准
Pub Date : 2004-09-20 DOI: 10.1300/J100V06N04_04
C. Frei, D. Burgess
{"title":"Community-acquired pneumonia: Objective criteria to predict severe disease","authors":"C. Frei, D. Burgess","doi":"10.1300/J100V06N04_04","DOIUrl":"https://doi.org/10.1300/J100V06N04_04","url":null,"abstract":"","PeriodicalId":190875,"journal":{"name":"Journal of Infectious Disease Pharmacotherapy","volume":"14 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2004-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115292192","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Development and Optimization of a Reversed Phase High Performance Liquid Chromatographic Method for the Determination of Levofloxacin in Growth Media, Human BAL Fluid, Alveolar Macrophages and Plasma 反相高效液相色谱法测定生长培养基、人BAL液、肺泡巨噬细胞和血浆中左氧氟沙星含量的建立与优化
Pub Date : 2004-09-20 DOI: 10.1300/J100V06N04_05
Cuilian Zhang
{"title":"Development and Optimization of a Reversed Phase High Performance Liquid Chromatographic Method for the Determination of Levofloxacin in Growth Media, Human BAL Fluid, Alveolar Macrophages and Plasma","authors":"Cuilian Zhang","doi":"10.1300/J100V06N04_05","DOIUrl":"https://doi.org/10.1300/J100V06N04_05","url":null,"abstract":"","PeriodicalId":190875,"journal":{"name":"Journal of Infectious Disease Pharmacotherapy","volume":"14 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2004-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126524603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Differential Effects of Amphotericin B and Fluconazole on Neutrophil CD11b Expression 两性霉素B和氟康唑对中性粒细胞CD11b表达的差异影响
Pub Date : 2004-09-20 DOI: 10.1300/J100V06N04_06
D. Healy
{"title":"Differential Effects of Amphotericin B and Fluconazole on Neutrophil CD11b Expression","authors":"D. Healy","doi":"10.1300/J100V06N04_06","DOIUrl":"https://doi.org/10.1300/J100V06N04_06","url":null,"abstract":"","PeriodicalId":190875,"journal":{"name":"Journal of Infectious Disease Pharmacotherapy","volume":"14 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2004-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126066070","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of Dietary Supplements with Claims of Antimicrobial Activity 具有抗菌活性的膳食补充剂的评价
Pub Date : 2004-01-27 DOI: 10.1300/J100V06N03_01
T. B. Klepser
{"title":"Evaluation of Dietary Supplements with Claims of Antimicrobial Activity","authors":"T. B. Klepser","doi":"10.1300/J100V06N03_01","DOIUrl":"https://doi.org/10.1300/J100V06N03_01","url":null,"abstract":"","PeriodicalId":190875,"journal":{"name":"Journal of Infectious Disease Pharmacotherapy","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2004-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114879720","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Role of a Clinical Pharmacist on Drotrecogin Alfa (activated) Outcomes in a Large Community Teaching Hospital 临床药师对大型社区教学医院羟曲霉素(激活)疗效的影响
Pub Date : 2004-01-27 DOI: 10.1300/J100V06N03_05
S. Kotapati
{"title":"Role of a Clinical Pharmacist on Drotrecogin Alfa (activated) Outcomes in a Large Community Teaching Hospital","authors":"S. Kotapati","doi":"10.1300/J100V06N03_05","DOIUrl":"https://doi.org/10.1300/J100V06N03_05","url":null,"abstract":"","PeriodicalId":190875,"journal":{"name":"Journal of Infectious Disease Pharmacotherapy","volume":"189 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2004-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124320972","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Pharmacoeconomic Aspects of Antibacterial Therapy with Azithromycin of Community-Acquired Pneumonia in Servicemen 阿奇霉素抗菌治疗军人社区获得性肺炎的药物经济学研究
Pub Date : 2004-01-27 DOI: 10.1300/J100V06N03_02
Olexander Dzyublyk
Study population The study population comprised male military servicemen between the ages of 18 and 21 years, with clinical symptoms and radiological evidence of pneumonia. The patients were classified as low risk in terms of short-term mortality and had not been given antibiotic treatment for 48 hours before treatment was started, unless it had resulted in no clinical improvement. Patients were excluded if they had a history of allergy to beta-lactams or macrolides, severe pneumonia, marked renal or hepatic impairment, or gastrointestinal disorders which could affect absorption. They were also excluded if they had received more than one daily dose of any antimicrobial drug prior to study enrolment.
研究人群包括年龄在18至21岁之间的男性军人,有肺炎的临床症状和放射学证据。这些患者在短期死亡率方面被划分为低风险,并且在开始治疗前48小时未给予抗生素治疗,除非没有导致临床改善。如果患者有β -内酰胺类或大环内酯类过敏史、严重肺炎、明显的肾脏或肝脏损害或可能影响吸收的胃肠道疾病,则排除。如果他们在研究入组前每天服用超过一剂量的抗菌药物,他们也被排除在外。
{"title":"Pharmacoeconomic Aspects of Antibacterial Therapy with Azithromycin of Community-Acquired Pneumonia in Servicemen","authors":"Olexander Dzyublyk","doi":"10.1300/J100V06N03_02","DOIUrl":"https://doi.org/10.1300/J100V06N03_02","url":null,"abstract":"Study population The study population comprised male military servicemen between the ages of 18 and 21 years, with clinical symptoms and radiological evidence of pneumonia. The patients were classified as low risk in terms of short-term mortality and had not been given antibiotic treatment for 48 hours before treatment was started, unless it had resulted in no clinical improvement. Patients were excluded if they had a history of allergy to beta-lactams or macrolides, severe pneumonia, marked renal or hepatic impairment, or gastrointestinal disorders which could affect absorption. They were also excluded if they had received more than one daily dose of any antimicrobial drug prior to study enrolment.","PeriodicalId":190875,"journal":{"name":"Journal of Infectious Disease Pharmacotherapy","volume":"31 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2004-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115211342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Appropriate Empiric Use of Antibiotics in Gram-Positive Infections:: Clinical Considerations 在革兰氏阳性感染中适当使用经验性抗生素:临床考虑
Pub Date : 2003-09-01 DOI: 10.1300/J100V04N04_02
J. Peterson
{"title":"Appropriate Empiric Use of Antibiotics in Gram-Positive Infections:: Clinical Considerations","authors":"J. Peterson","doi":"10.1300/J100V04N04_02","DOIUrl":"https://doi.org/10.1300/J100V04N04_02","url":null,"abstract":"","PeriodicalId":190875,"journal":{"name":"Journal of Infectious Disease Pharmacotherapy","volume":"14 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2003-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126863619","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Considerations Regarding the Administration of Beta-Lactam Antibiotics by Continuous Infusion 持续输注β -内酰胺类抗生素的临床考虑
Pub Date : 2003-09-01 DOI: 10.1300/J100V04N04_01
E. Grant
{"title":"Clinical Considerations Regarding the Administration of Beta-Lactam Antibiotics by Continuous Infusion","authors":"E. Grant","doi":"10.1300/J100V04N04_01","DOIUrl":"https://doi.org/10.1300/J100V04N04_01","url":null,"abstract":"","PeriodicalId":190875,"journal":{"name":"Journal of Infectious Disease Pharmacotherapy","volume":"75 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2003-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124029478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Journal of Infectious Disease Pharmacotherapy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
﹀
mjeditor
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1